Absorption |
Blood-Brain Barrier | BBB- | 0.9833 |
Human Intestinal Absorption | HIA+ | 0.7183 |
Caco-2 Permeability | Caco2- | 0.8232 |
P-glycoprotein Substrate | Substrate | 0.7092 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8020 |
Non-inhibitor | 0.9317 |
Renal Organic Cation Transporter | Non-inhibitor | 0.9464 |
Distribution |
Subcellular localization | Mitochondria | 0.7507 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8384 |
CYP450 2D6 Substrate | Non-substrate | 0.8989 |
CYP450 3A4 Substrate | Substrate | 0.6228 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.9046 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9071 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9230 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9026 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8309 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8019 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9950 |
Non-inhibitor | 0.7584 |
AMES Toxicity | Non AMES toxic | 0.8374 |
Carcinogens | Non-carcinogens | 0.8692 |
Fish Toxicity | High FHMT | 0.9902 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9369 |
Honey Bee Toxicity | Low HBT | 0.6537 |
Biodegradation | Not ready biodegradable | 0.9955 |
Acute Oral Toxicity | III | 0.8019 |
Carcinogenicity (Three-class) | Non-required | 0.6904 |